Systematic characterization of single-cell full-length RNA isoforms in human colorectal cancer

Dysregulated RNA splicing is a well-recognized characteristic of colorectal cancer (CRC); however, its intricacies remain obscure, partly due to challenges in profiling full-length transcript variants at single-cell level. Here, we employ high-depth long-read scRNA-seq to define the full-length transcriptome of colorectal epithelial cells in 12 CRC patients, revealing extensive isoform diversities and splicing alterations. Cancer cells exhibited increased transcript complexity, with widespread 3'-UTR shortening and reduced intron retention. Distinct splicing regulation patterns were observed between intrinsic-consensus molecular subtypes (iCMS), with iCMS3 displaying even higher splicing factor activities and more pronounced 3'-UTR shortening. Furthermore, we revealed substantial shifts in isoform usage that result in alterations of protein sequences from the same gene with distinct carcinogenic effects during tumorigenesis of CRC. Allele-specific expression analysis revealed dominant mutant allele expression in key oncogenes and tumor suppressors. Moreover, mutated PPIG was linked to widespread splicing dysregulation, and functional validation experiments confirmed its critical role in modulating RNA splicing and tumor-associated processes. Our findings highlight the transcriptomic plasticity in CRC and suggest potentially novel targets for splicing-based therapeutic strategies. To investigate the heterogeneities of full-length transcriptome in CRC, we performed long-read scRNA-seq on CD45-EPCAM+ cells isolated from primary tumors (PT) and adjacent normal tissues (NT) of 12 CRC patients. *************************************************************** The raw data have been deposited at The Genome Sequence Archive for Human (GSA-Human) under accession codes HRA006041 and HRA010639 (BioProject accession: PRJCA021256) and are publicly available at https://ngdc.cncb.ac.cn/gsa-human. ***************************************************************